Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2001
11/01/2001CA2407377A1 Dna & protein binding miniature proteins
11/01/2001CA2407352A1 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001CA2407167A1 Thrombopoietin receptor modulating peptide
11/01/2001CA2407114A1 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001CA2407086A1 Integrin/adhesion antagonists
11/01/2001CA2407084A1 Isolated human transporter proteins, nucleic acids and uses thereof
11/01/2001CA2407083A1 Apo-ai/aii peptide derivatives
11/01/2001CA2407081A1 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
11/01/2001CA2407077A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/01/2001CA2407053A1 Pneumovirus ns proteins antagonize the interferon (ifn) response
11/01/2001CA2407050A1 Alphavirus-based vectors for persistent infection
11/01/2001CA2406990A1 Mre11 orthologue and uses thereof
11/01/2001CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001CA2406839A1 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001CA2406736A1 Nucleic acids that control plant development
11/01/2001CA2406725A1 Edg8 receptor, its preparation and use
11/01/2001CA2406660A1 Heteromultimeric ion channel receptor and uses thereof
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406004A1 Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
11/01/2001CA2405985A1 Nk-2 homeobox transcription factor
11/01/2001CA2405983A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001CA2405551A1 Diagnostic and therapeutic methods using the h37 tumor suppressor gene
11/01/2001CA2405138A1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
10/2001
10/31/2001EP1149919A2 Genes related to biosynthesis of ML-236B
10/31/2001EP1149916A2 Defective Adenoviruses and corresponding transcomplementant cell lines
10/31/2001EP1149913A1 Cytokine immunoconjugates
10/31/2001EP1149910A1 Pharmaceutical composition for treating papillomavirus tumours and infection
10/31/2001EP1149909A1 Methods for regulating protein conformation using molecular chaperones
10/31/2001EP1149908A1 TGF-beta type receptor cDNAs and uses thereof
10/31/2001EP1149907A1 EDG8 receptor, its preparation and use
10/31/2001EP1149906A1 Thrombopoietin receptor modulating peptide
10/31/2001EP1149905A1 Methods and compositions for polypeptide engineering
10/31/2001EP1149904A1 Methods and compositions for polypeptide engineering
10/31/2001EP1149901A1 Pestivirus mutants and vaccines containing the same
10/31/2001EP1149844A2 Truncated reelin protein and DNA encoding the same
10/31/2001EP1149587A2 Construction of Pasteurella heamolytica vaccines
10/31/2001EP1149582A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor). Uses thereof
10/31/2001EP1149171A1 Foamy virus vectors for expressing foreign genes in mammals and the use thereof
10/31/2001EP1149168A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
10/31/2001EP1149167A2 Viral vaccine
10/31/2001EP1149166A2 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)
10/31/2001EP1149165A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof
10/31/2001EP1149164A2 Neisseria meningitidis polypeptides
10/31/2001EP1149163A2 Human serum albumin
10/31/2001EP1149162A2 Medicament
10/31/2001EP1149159A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
10/31/2001EP1149158A1 Genetic and epigenetic regulation of abc transporters and ect0-phosphatases for the modulation of drug resistance
10/31/2001EP1149115A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41
10/31/2001EP1149114A2 Polypeptides involved in immune response
10/31/2001EP1149112A2 Ewing's tumour antigen, nucleic acid and antibodies
10/31/2001EP1148897A1 Methods and compositions for healing and repair of articular cartilage
10/31/2001EP1148888A2 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
10/31/2001EP1148782A2 Plant resistance to insect pests mediated by viral proteins
10/31/2001EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/31/2001EP0833652A4 Novel kappa receptor selective opioid peptides
10/31/2001EP0779896B1 New process for the production of biologically active protein (tgf)
10/31/2001EP0775159B1 Novel process for the production of biologically active dimeric protein
10/31/2001EP0775157B1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof
10/31/2001EP0699077B1 Hiv immunogenic complexes
10/31/2001EP0693085B1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof
10/31/2001EP0626998B1 Production of viral resistant plants via introduction of untranslatable plus sense viral rna
10/31/2001EP0519001B1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
10/31/2001EP0444181B1 C-erbb-2 external domain: gp75
10/31/2001EP0201540B2 Envelope antigens of lymphadenopathy associated virus and their applications
10/31/2001DE10020505A1 RSV NS Proteine antagonisieren die Interferon (IFN) Antwort RSV NS proteins antagonize the interferon (IFN) response
10/31/2001DE10019135A1 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung Polyamide nucleic acid derivatives, means, and methods for their preparation
10/31/2001DE10019075A1 Verwendung von CD34 oder einem davon abgeleiteten Polypeptid als Zell-Oberflächen- bzw. Gentransfer-Marker Use of CD34 or a polypeptide derived as a cell-surface markers or gene transfer
10/31/2001CN1320165A Antithrombin nucleotides and proteins from horn fly
10/31/2001CN1320164A Novel collectin
10/31/2001CN1320163A Method for triggering apoptosis in cells
10/31/2001CN1320043A Mutant cholera holotoxin as an adjuvant
10/31/2001CN1319671A Novel secretion expression vector and its application of recombinant hirudin expression technology
10/31/2001CN1319666A Human testis development relative gene coding protein
10/31/2001CN1319665A Human testics kinesin 9 gene coding protein
10/31/2001CN1319612A Novel polypeptide-human scorpion short chain toxin protein 9 and polynucleotide for encoding said polypeptide
10/31/2001CN1319611A Novel polypeptide-human MAGE antigen 51 and polynucleotide for encoding said polypeptide
10/31/2001CN1319610A Novel polypeptide-human corticotrophin releasing factor 23 and polynucleotide for encoding said polypeptide
10/31/2001CN1319608A Novel polypeptide-human corticotrophin releasing factor 26 and polynucleotide for encoding said polypeptide
10/31/2001CN1319607A Novel polypeptide-human anky rin homoplastic protein 57 and polynucleotide for coding said polypeptide
10/31/2001CN1319606A Novel polypeptide-human actin formation regulator 30 and polynucleotide for encoding said polypeptide
10/31/2001CN1319605A Antitumour polypeptide and gene therapy vector composition
10/31/2001CN1319604A Novel polypeptide-ribosomal protein L15e25 and polynucleotide for encoding said polypeptide
10/31/2001CN1319603A Novel polypeptide-geminivirus motion protein 19 and polynucloetide for encoding said polypeptide
10/30/2001US6310275 Artificially synthesized gene for trypsin inhibitor
10/30/2001US6310272 Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same
10/30/2001US6310197 Nucleotide sequences for use in treatment of alzheimer's disease
10/30/2001US6310196 DNA construct for immunization or gene therapy
10/30/2001US6310195 Nucleic acid encoding a lectin-derived progenitor cell preservation factor
10/30/2001US6310193 Nucleotide sequences for use in the detection of microorganism; for use in screening bactericides
10/30/2001US6310192 SigB
10/30/2001US6310190 USPA1 and USPA2 antigens of Moraxella catarrhalis
10/30/2001US6310182 Polypeptide for use in treatment of intracellular vesicular defects
10/30/2001US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001US6310180 Method for synthesis of proteins
10/30/2001US6310179 2-or 3-dimensional geometric structures
10/30/2001US6310177 Compounds and methods for modulating tissue permeability
10/30/2001US6310176 Antimicrobially active polypeptides
10/30/2001US6310048 Antisense nucleotides coding given amino acid sequence of amyloid precursor protein (app) inhibit the expression of an amyloid beta protein (abp) portion of app while permitting expression of app polynucleotide 5' to the abp portion
10/30/2001US6310046 Encoded by isolated dna; diagnosis of and immunization against malaria
10/30/2001US6310045 Compositions and methods for cancer immunotherapy
1 ... 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 ... 2916